Inflammation is a common factor of chronic periodontitis and diabetes. However, to date, there is no scientific evidence supporting a causal effect of the inflammation created by apical periodontitis on the onset of insulin resistance and on metabolic derangement in the condition of pre-diabetes or diabetes. A case control study has been designed in order to evaluate serum levels of pro-diabetes inflammation factors in a sample of healthy patients between 25 and 55 years of age, with or without apical periodontitis,before endodontic treatment and at 6 and 12 months post-treatment. The aim of the study is to evaluate any relation between the presence of chronic endodontic lesions and pro-diabetes inflammation factors that can promote the onset of insulin resistance, and whether endodontic treatment can reduce these factors, thus preventing a pro-diabetes status.
Healthy, consenting and informed patients of both gender under 55 years of age with apical periodontitis will be enrolled as cases. Healthy, consenting and informed patients of both gender under 55 years of age without apical periodontitis will be enrolled as control subjects. The study has been designed to assess the serum level of TNF-α, IL-1β, IL-6, IL-8 by ELISA assay.
Study Type
OBSERVATIONAL
Enrollment
27
Department of Oncology - University of Turin
Turin, Italy
Endodontics, Department of Surgical Sciences - Univeristy of Turin
Turin, Italy
Variation in pro-diabetes inflammation markers over time upon endodontic intervention.
Dosage of TNF-α, IL-1β, IL-6, IL-8 (pg/mL) in serum(ng/10\^6 platelets) by ELISA assay.
Time frame: Baseline serum levels of selected pro-diabetes inflammation markers in control group and AP group.
Variation in pro-diabetes inflammation markers over time upon endodontic intervention.
Dosage of TNF-α, IL-1β, IL-6, IL-8 (pg/mL) in serum by ELISA assay.
Time frame: Serum levels of selected pro-diabetes inflammation markers at 6 months after endodontic treatment and in control group.
Variation in pro-diabetes inflammation markers over time upon endodontic intervention.
Dosage of TNF-α, IL-1β, IL-6, IL-8 (pg/mL) in serum by ELISA assay.
Time frame: Serum levels of selected pro-diabetes inflammation markers at 12 months after endodontic treatment and in control group.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.